Glycanostics is an innovative start-up company that specializes in early stage, highly accurate, and unique cancer diagnostics. Our cutting-edge technology detects glycan changes, which are complex carbohydrates attached to proteins in the blood, allowing for the detection of early-stage cancers. What sets us apart is our ability to provide highly scalable cancer screening solutions.

At Glycanostics, we are committed to revolutionizing medicine and improving patient outcomes. Our dedicated team, including our experienced executive team, supervisory board, and advisory board, works tirelessly to advance our science and bring it to the forefront of the medical field. We are proud to announce that our efforts have been recognized, as evidenced by the numerous publications, events, and collaborations we have been involved in.

Additionally, we are excited to share that we have recently received our first patent certificate for our European Patent. To expand our reach and provide our services to more patients, we are actively collaborating with urologists and specialist urology clinics. Our network is constantly growing, allowing more individuals to benefit from our highly accurate prostate cancer test, the Giasay® PROSTATE test.

Join us in shaping the future of cancer diagnostics and stay up to date with our latest news and upcoming events. Follow us on Twitter, LinkedIn, and YouTube for the latest updates from Glycanostics